000 01473 a2200421 4500
005 20250516044304.0
264 0 _c20111227
008 201112s 0 0 eng d
022 _a1873-3476
024 7 _a10.1016/j.ijpharm.2011.06.024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSantos, P
245 0 0 _aFormulation issues associated with transdermal fentanyl delivery.
_h[electronic resource]
260 _bInternational journal of pharmaceutics
_cSep 2011
300 _a155-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdministration, Cutaneous
650 0 4 _aCellulose
_xanalogs & derivatives
650 0 4 _aChemistry, Pharmaceutical
_xmethods
650 0 4 _aCrystallization
650 0 4 _aDiffusion Chambers, Culture
650 0 4 _aExcipients
_xchemistry
650 0 4 _aFentanyl
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMembranes, Artificial
650 0 4 _aPermeability
_xdrug effects
650 0 4 _aPolymers
_xchemistry
650 0 4 _aPropylene Glycol
_xchemistry
650 0 4 _aSkin
_xdrug effects
650 0 4 _aSkin Absorption
_xdrug effects
650 0 4 _aSolubility
700 1 _aWatkinson, A C
700 1 _aHadgraft, J
700 1 _aLane, M E
773 0 _tInternational journal of pharmaceutics
_gvol. 416
_gno. 1
_gp. 155-9
856 4 0 _uhttps://doi.org/10.1016/j.ijpharm.2011.06.024
_zAvailable from publisher's website
999 _c20976744
_d20976744